69697-46-7

Usage

Uses

Used in Pharmaceutical Industry:
4-Isopropoxycyclohexanone is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its ability to form carbon-carbon and carbon-oxygen bonds makes it instrumental in the development of new drugs and medicinal agents.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Isopropoxycyclohexanone serves as a key intermediate in the production of pesticides and other crop protection agents, contributing to the development of effective and sustainable agricultural solutions.
Used in Organic Synthesis:
4-Isopropoxycyclohexanone is utilized as a reagent in organic synthesis reactions, where its capacity to form essential chemical bonds is crucial for creating a wide array of organic compounds, including those with specific applications in various industries.
Used in Production of Fine Chemicals:
4-Isopropoxycyclohexanone is employed as a building block in the synthesis of fine chemicals, which are high-purity, specialty chemicals used in various applications such as fragrances, flavors, dyes, and other high-value products.

Upstream product

• 22428-87-1 4,4-ethylenedioxycyclohexan-1-ol 
• 75-30-9 2-iodo-propane 
• 950771-91-2 8-isopropoxy-1,4-dioxaspiro[4.5]decane 
• 4746-97-8 cyclohexanedione monoethylene ketal 

Downstream Products

• 950771-93-4 1,1-dimethylethyl (1-{trans-4-[(1-methylethyl)oxy]cyclohexyl}-4-piperidinyl)carbamate 
• 1217800-47-9 (4-isopropoxy-cyclohexylidene)-acetic acid methyl ester 
• 1425971-71-6 1-{4-[(1-cyclobutylpiperidin-4-ylidene)methyl]phenyl}-4-(propan-2-yloxy)cyclohexanol 
• 1425971-70-5 1-{4-[(1-cyclobutylpiperidin-4-ylidene)methyl]phenyl}-4-(propan-2-yloxy)cyclohexanol 
• 950771-96-7 1-{trans-4-[(1-methylethyl)oxy]cyclohexyl}-N-(5-methyl-2-nitrophenyl)-4-piperidinamine 
• 950771-97-8 (2-amino-5-methylphenyl)(1-{trans-4-[(1-methylethyl)oxy]cyclohexyl}-4-piperidinyl)amine 
• 1342811-33-9 C₁₅H₂₂BrN₃O 

Relevant academic research and scientific papers

Synthesis method of 4-substituent cyclohexanone

The invention discloses a synthesis method of 4-substituent cyclohexanone, which comprises the following steps: by taking a 4-substituent phenol compound as a raw material, carrying out catalytic hydrogenation on 4-substituent phenol to obtain 4-substituent cyclohexanol, and then oxidizing the 4-substituent cyclohexanol by taking oxygen-containing gas as an oxidant to prepare the 4-substituent cyclohexanone. The oxygen-containing gas is used as the oxidizing agent, the oxygen-containing gas is low in price, good in reaction selectivity, high in oxidation reaction yield and environment-friendly, and is an ideal clean oxidizing agent; in addition, the whole synthesis process is simple, mild in condition, simple in post-treatment, green, environment-friendly and suitable for large-scale industrial production.

CARBOXAMIDE DERIVATIVES

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins

The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.

D3 AND 5-HT2A RECEPTOR MODULATORS

The present invention provides compounds of the general formula (I) wherein X, n and R1 are as described herein, as well as pharmaceutically acceptable salts and esters thereof, methods for their manufacture, pharmaceutical compositions contain

NOVEL COMPOUNDS-300

Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, m, n, q, s, t, X, and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of formula (I), salts and solvates are provided: formula (I), wherein Q, R and R6 are as defined in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.

BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of Formula (I) and salts and solvates are provided; wherein R, R5, R6 and Q are defined as in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.